Evidence map›Paper›PMID 25719435›Full record

ArticleAnalytical chemistry2015

Microfluidic multiculture assay to analyze biomolecular signaling in angiogenesis.

Ashleigh B Theberge, Jiaquan Yu, Edmond W K Young, William A Ricke, Wade Bushman, David J Beebe

Abstract read
In one paragraph

Article in Analytical chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Insert-based microfluidics for 3D cell culture with analysis.Analytical and bioanalytical chemistry · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Vasculature-On-A-Chip for In Vitro Disease Models.Bioengineering (Basel, Switzerland) · 2017
    Review
  17. A Critical Analysis of the AvailableJournal of ophthalmology · 2017
    Review
  18. Article
  19. Review
  20. Organ-on-a-Chip: New Platform for Biological Analysis.Analytical chemistry insights · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ashleigh B Theberge†Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Jiaquan Yu†Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Edmond W K Young†Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
William A Ricke§Department of Urology, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Wade Bushman§Department of Urology, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
David J Beebe†Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Role of Beta-Catenin in Urinary DysfunctionU54DK104310 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI MACOSKA, JILL A., MARKER, PAUL C · 2014 to 2023
$12.8M
Molecular & Environmental Toxicology Pre-& Postdoctoral Training ProgramT32ES007015 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPHER A BRADFIELD · 1985 to 2026
$11.5M
Wisconsin Multidisciplinary K12 Urologic Research Career Development ProgramK12DK100022 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI CHAD M. VEZINA · 2013 to 2026
$8.6M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma CellsR01CA155192 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, MIYAMOTO, SHIGEKI · 2012 to 2016
$1.4M
Estrogen Regulation in BPH and the Lower Urinary TractR01DK093690 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI RICKE, WILLIAM A · 2011 to 2014
$1.3M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 01 CA155192NCI NIH HHS R01 CA155192NIBIB NIH HHS R01 EB010039NIBIB NIH HHS R01EB010039NIDDK NIH HHS K12 DK100022NIDDK NIH HHS K12DK100022NIDDK NIH HHS R01 DK093690NIDDK NIH HHS U54 DK104310NIEHS NIH HHS T32 ES007015NIEHS NIH HHS T32ES007015
6 · The paper itself

Abstract

Angiogenesis (the formation of blood vessels from existing blood vessels) plays a critical role in many diseases such as cancer, benign tumors, and macular degeneration. There is a need for cell culture methods capable of dissecting the intricate regulation of angiogenesis within the microenvironment of the vasculature. We have developed a microscale cell-based assay that responds to complex pro- and antiangiogenic soluble factors with an in vitro readout for vessel formation. The power of this system over traditional techniques is that we can incorporate the whole milieu of soluble factors produced by cells in situ into one biological readout (vessel formation), even if the identity of the factors is unknown. We have currently incorporated macrophages, endothelial cells, and fibroblasts into the assay, with the potential to include additional cell types in the future. Importantly, the microfluidic platform is simple to operate and multiplex to test drugs targeting angiogenesis in a more physiologically relevant context. As a proof of concept, we tested the effect of an enzyme inhibitor (targeting matrix metalloproteinase 12) on vessel formation; the triculture microfluidic assay enabled us to capture a dose-dependent effect entirely missed in a simplified coculture assay (p < 0.0001). This result underscores the importance of cell-based assays that capture chemical cross-talk occurring between cell types. The microscale dimensions significantly reduce cell consumption compared to conventional well plate platforms, enabling the use of limited primary cells from patients in future investigations and offering the potential to screen therapeutic approaches for individual patients in vitro.

Indexed as

Neovascularization, PhysiologicSignal TransductionCell LineCellular MicroenvironmentDose-Response Relationship, DrugEndothelial CellsEquipment DesignFibroblastsHumansMacrophagesMatrix Metalloproteinase 12Matrix Metalloproteinase InhibitorsMicrofluidic Analytical TechniquesSolubilityMatrix Metalloproteinase 12Matrix Metalloproteinase Inhibitors

Identifiers

PMID25719435
PMCPMC4405103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.